ATRIUM THERAPEUTICS INC
RNA·04965N104·US·Common Stock-13D/G
RNA (ATRIUM THERAPEUTICS INC) is held by 91 institutional investors as of Q1 2026. Largest holders: PRICE T ROWE ASSOCIATES INC /MD/ ($20.8M), BlackRock, Inc. ($16.1M), RA CAPITAL MANAGEMENT, L.P. ($11.6M). Net institutional sentiment: Bullish. In Q1 2026, 1 member of Congress and 91 funds bought RNA.
91
Holders
(5 Elite)
$134.4M
Total Value
100% (91)
Consensus
91 buying - 0 selling
13F: Insider & Congress:
Who's Trading
InsiderBSBoyce SarahSell $463KJan 21, 2026
InsiderBSBoyce SarahSell $579KJan 21, 2026
InsiderMTMcCarthy TeresaSell $107KJan 21, 2026
InsiderMTMcCarthy TeresaSell $105KJan 21, 2026
Top Holders
Showing 1-20 of 91
1 / 5
Continue exploring
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer